-
Naše izkušnje pri zdravljenju anemije z eritropoietinom pri otroku z rakom = Erythropoietin treatment for anemia in children with cancer - single centre experiencesMali, Polonca, dr. med. ...Background. Anemia, a common complication during treatment of malignant disease in children, was frequently treated with red blood cell transfusions. Several studies have shown, that the introduction ... of recombinant human erythropoietin (rh EPO) for treating anemia in patients has been effective in reducing the need for transfusions. Variable doses of EPO from 150 to 900 1U/kg body weight have been used usually three times weekly. Recently some studies showed equally effective once weekly administration of EPO with proposed doses for children of 450 to 600 IU/ kg body weight. Efficacy and safety of once weekly EPO therapy was tested in 8/10 children treated in our Unit for solid tumors and nonHodgkin's lymphoma. In this article we would liketo present our one year experience with EPO treatment. Patients and methods. Patients have subcutaneously received the EPO dose of 600 UI/kg body weight once weekly. Hemoglobin response and transfusion needs before and during treatment with EPO were analyzed. Results. Response was seen in 7/8 of patient, with increased hemoglobin level and lower transfusion needs. Only onepatient was poor responder at first, but responded perfect after twice weekly EPO application. No adverse reaction related to EPO therapy was observed. Condusions. Our experience with treating anemia in pediatric cancer patients who undergo intensive and aggressive chemotherapy treatment regimens are good and promising. Once weekly dosage regimen is child friendly and acceptable way of treating anemia.Vir: Številka ob 2. kongresu hematologov in transfuziologov Slovenije z mednarodno udeležbo (str. I-43-I-46)Vrsta gradiva - prispevek na konferenci ; neleposlovje za odrasleLeto - 2004Jezik - slovenskiCOBISS.SI-ID - 17679833
Avtor
Mali, Polonca, dr. med. |
Kitanovski, Lidija |
Jazbec, Janez, 1962- |
Anžič, Jožica, zdravnica |
Benedik-Dolničar, Majda
Teme
Neoplasms |
Anemia |
Therapy |
Erythropoietin, Recombinant |
Child |
Hemoglobins |
Erythrocyte Transfusion |
Treatment Outcome |
Anemija |
Eritropoietin rekombinantni |
Novotvorbe |
Eritrocitna transfuzija |
Hemoglobini |
Otrok |
Zdravljenje, izid
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Mali, Polonca, dr. med. | 38459 |
Kitanovski, Lidija | 19257 |
Jazbec, Janez, 1962- | 10972 |
Anžič, Jožica, zdravnica | 03563 |
Benedik-Dolničar, Majda | 03564 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.